Liposomal Amphotericin in Disseminated Leishmaniasis
NCT02025491
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Disseminated Leishmaniasis
Interventions
DRUG:
Liposomal Amphotericin B
Sponsor
Hospital Universitário Professor Edgard Santos